Research Library

Concerned about high medical bills, uninsured Texans are twice as likely as the insured to delay or forgo health care. That’s one of the findings of a new survey released today by Rice University’s Baker Institute for Public Policy and the Episcopal Health Foundation.

In this commentary, the authors examine the roots of the United States’ reluctance to embrace universal health care, concluding that it "is neither sound nor ethical in a nation that promulgates fairness and equal opportunity" to deny coverage.

While the Food and Drug Administration currently regulates storage and use of cord blood (CB) in the United States, other state and federal guidelines on CB education, awareness and ethical considerations remain variable, and no mandatory international guidelines exist. To help organize and coordinate efforts across the United States and other nations, policymakers should implement regulations for high quality standards for both private and public CB banks.

Texas’ uninsured population remains primarily Hispanic, middle-aged, with low incomes and without a college degree, according to a report released July 30 by Rice University’s Baker Institute for Public Policy and the Episcopal Health Foundation.

While the recent fiscal troubles in Greece have received much attention, the U.S. fiscal position is hardly comparable to that of Greece. However, the United States is experiencing, and will continue to experience, one of the fundamental economic costs of relatively large and persistent deficits.

This paper reviews the literature on asthma management programs for children and discusses the implications and recommendations for asthma management programs, future research and policy development.

Despite enviable increases in educational attainment, women in the MENA countries may fare less well in attaining a form of social capital integral to their ability to exercise full political, economic and social agency: wasta — loosely, clout, or using one’s connections and/or influence to get things done.

Asthma in children costs an estimated $27 billion annually for doctor visits, emergency department visits and hospitalizations. Not surprisingly, kids with asthma miss more days of school and do worse academically. The first step to the management and treatment of asthma is access to a primary care provider who can prescribe the necessary medications and develop an asthma action plan. However, if we want to have a significant impact on the negative consequences of this disease on our children, a multi-faceted approach that includes policy is an absolute must.

Regenerative medicine and stem cell research are exciting new fields. But as the fields progress toward clinical therapies, controversies emerge. Hype surrounding stem cell research has caused an increase in their use in interventions that are not clinically proven. Furthermore, the regulatory agencies have a lot of difficulty dealing with cell therapies, which are distinctly different from drugs and medical devices they more commonly approve. To move the field forward, advocates, regulators and scientists need to come together to find new options for stem cell research oversight that protects both the patients and the research field.

While global attention in West Africa is focused on the emergence of Ebola virus infection, new information from the published literature and World Health Organization databases reveals that many other neglected tropical diseases are far more widespread and also require urgent attention.